Fuan Pharmaceutical Group Co (300194) — Cash Flow Reinvestment Rate
Fuan Pharmaceutical Group Co (300194) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥22.81 Million (capex CN¥22.81 Million ) from operating cash flow of CN¥100.27 Million. See Fuan Pharmaceutical Group Co free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Fuan Pharmaceutical Group Co Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Fuan Pharmaceutical Group Co across 18 annual periods. For the full cash flow conversion analysis, see 300194 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Fuan Pharmaceutical Group Co (2007–2025)
Year-by-year capital reinvestment analysis for Fuan Pharmaceutical Group Co. See Fuan Pharmaceutical Group Co financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.65x | CN¥204.53 Million | CN¥312.32 Million | CN¥108.43 Million | ▼ -23.3% |
| 2024 | 0.85x | CN¥259.26 Million | CN¥303.59 Million | CN¥241.79 Million | ▼ -9.2% |
| 2023 | 0.94x | CN¥309.30 Million | CN¥328.98 Million | CN¥215.68 Million | ▼ -61.2% |
| 2022 | 2.42x | CN¥823.11 Million | CN¥339.50 Million | CN¥383.10 Million | ▲ +42.3% |
| 2021 | 1.70x | CN¥438.18 Million | CN¥257.13 Million | CN¥413.03 Million | ▼ -30.2% |
| 2020 | 2.44x | CN¥396.76 Million | CN¥162.55 Million | CN¥344.53 Million | ▲ +171.9% |
| 2019 | 0.90x | CN¥265.34 Million | CN¥295.63 Million | CN¥223.80 Million | ▼ -5.1% |
| 2018 | 0.95x | CN¥253.16 Million | CN¥267.68 Million | CN¥132.16 Million | ▲ +71.1% |
| 2017 | 0.55x | CN¥250.62 Million | CN¥453.37 Million | CN¥84.62 Million | ▼ -80.2% |
| 2016 | 2.79x | CN¥1.04 Billion | CN¥374.16 Million | CN¥153.91 Million | ▼ -4.0% |
| 2015 | 2.91x | CN¥468.58 Million | CN¥161.03 Million | CN¥92.16 Million | ▲ +51.6% |
| 2013 | 1.92x | CN¥171.97 Million | CN¥89.61 Million | CN¥171.97 Million | ▼ -9.1% |
| 2012 | 2.11x | CN¥132.44 Million | CN¥62.77 Million | CN¥132.44 Million | ▲ +35.6% |
| 2011 | 1.56x | CN¥100.92 Million | CN¥64.85 Million | CN¥100.92 Million | ▲ +139.4% |
| 2010 | 0.65x | CN¥68.74 Million | CN¥105.74 Million | CN¥68.74 Million | ▲ +31.4% |
| 2009 | 0.49x | CN¥31.04 Million | CN¥62.75 Million | CN¥31.04 Million | ▼ -29.4% |
| 2008 | 0.70x | CN¥34.48 Million | CN¥49.23 Million | CN¥34.48 Million | ▼ -9.1% |
| 2007 | 0.77x | CN¥14.58 Million | CN¥18.92 Million | CN¥14.58 Million | — |